News
Conshohocken, Pennsylvania Thursday, August 21, 2025, 14:00 Hrs [IST] ...
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) has announced that the European Commission (EC) has granted conditional ...
Although there are other treatments in development, Wegovy could carve out a decent market for itself in MASH, especially ...
11h
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback